BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11675573)

  • 61. Levels of lipoprotein(a) and plasma lipids in Spanish children aged from 4 to 18 years.
    Gómez Gerique JA; Porres A; López Martinez D; Alvarez Sala LA; Blazquez E; Montoya MT; De Oya M
    Acta Paediatr; 1996 Jan; 85(1):38-42. PubMed ID: 8834977
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Serum neopterin levels in patients with hepatocellular carcinoma.
    Antoniello S; Auletta M; Magri P; Russo N
    Biol Chem Hoppe Seyler; 1992 Nov; 373(11):1165-8. PubMed ID: 1282321
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Association between metabolic abnormalities and HBV related hepatocelluar carcinoma in Chinese: a cross-sectional study.
    Zhao J; Zhao Y; Wang H; Gu X; Ji J; Gao C
    Nutr J; 2011 May; 10():49. PubMed ID: 21569630
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ethnicity may be a reason for lipid changes and high Lp(a) levels in rheumatoid arthritis.
    Cesur M; Ozbalkan Z; Temel MA; Karaarslan Y
    Clin Rheumatol; 2007 Mar; 26(3):355-61. PubMed ID: 16680389
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Changes in lipoprotein (a) [Lp(a)] level after an ischemic stroke].
    Wehr H; Rado M; Mendel T; Swiderska M; Bednarska-Makaruk M; Szirkowiec W
    Neurol Neurochir Pol; 2004; 38(3):197-200. PubMed ID: 15354232
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Lipoprotein (a) serum levels in patients with hepatocarcinoma.
    Basili S; Andreozzi P; Vieri M; Maurelli M; Cara D; Cordova C; Alessandri C
    Clin Chim Acta; 1997 Jun; 262(1-2):53-60. PubMed ID: 9204209
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Lipoprotein (a) and cholesterol in body builders using anabolic androgenic steroids.
    Cohen LI; Hartford CG; Rogers GG
    Med Sci Sports Exerc; 1996 Feb; 28(2):176-9. PubMed ID: 8775151
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The effect of nicotinic acid and acipimox on lipoprotein(a) concentration and turnover.
    Seed M; O'Connor B; Perombelon N; O'Donnell M; Reaveley D; Knight BL
    Atherosclerosis; 1993 Jun; 101(1):61-8. PubMed ID: 8216503
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long distance runners and body-builders exhibit elevated plasma levels of lipoprotein(a).
    Cardoso GC; Posadas C; Orvanaños OO; Peniche C; Zamora J; Aguilar R; Holguin JA; Raynaud AS; Morrisett JD; Guevara J
    Chem Phys Lipids; 1994 Jan; 67-68():207-21. PubMed ID: 8187216
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A Hepatocellular Carcinoma Aggressiveness Index and Its Relationship to Liver Enzyme Levels.
    Carr BI; Guerra V
    Oncology; 2016; 90(4):215-20. PubMed ID: 26974336
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical characteristics of patients under 40 years old with early-onset hyperuricaemia: a retrospective monocentric study in China.
    Zhang Y; Yang Y; Xue L; Wen J; Bo L; Tang M; Yang R; Yan D; Liu Z
    BMJ Open; 2019 Aug; 9(8):e025528. PubMed ID: 31462461
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Increased plasma apoM levels in the patients suffered from hepatocellular carcinoma and other chronic liver diseases.
    Jiang J; Zhang X; Wu C; Qin X; Luo G; Deng H; Lu M; Xu B; Li M; Ji M; Xu N
    Lipids Health Dis; 2008 Jul; 7():25. PubMed ID: 18652652
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Lipoprotein (a) in childhood: correlations with family history of cardiovascular disease.
    De Simone M; Verrotti A; Cappa M; Iughetti L; Di Cesare E; Palumbo M; Bernabei R; Rosato T
    J Endocrinol Invest; 2003 May; 26(5):414-9. PubMed ID: 12906368
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A study of serological markers and lipid profile in non-alcoholic liver cirrhosis patients.
    Khan S; Jamal S
    Pak J Pharm Sci; 2018 Jan; 31(1):89-93. PubMed ID: 29348089
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Lipoprotein(a) and lipid profile in patients with atrial fibrillation.
    Díaz-Peromingo JA; Albán-Salgado A; García-Suárez F; Sánchez-Leira J; Saborido-Froján J; Iglesias-Gallego M
    Med Sci Monit; 2006 Mar; 12(3):CR122-5. PubMed ID: 16501423
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Circulating intercellular adhesion molecule-1 in patients with hepatocellular carcinoma.
    Soresi M; Cervello M; Lipani G; Carroccio A; Cartabellotta A; Marasà L; Casto C; Virruso L; Montalto G
    Eur J Gastroenterol Hepatol; 1997 Aug; 9(8):805-9. PubMed ID: 9282280
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Reduced serum lipoprotein(a) levels in patients with primary biliary cirrhosis.
    Gregory WL; Game FL; Farrer M; Idle JR; Laker MF; James OF
    Atherosclerosis; 1994 Jan; 105(1):43-50. PubMed ID: 8155087
    [TBL] [Abstract][Full Text] [Related]  

  • 78. High serum levels of secretory component in hepatocellular carcinoma.
    Kew MC; Vincent C; Rossel M; Revillard JP
    Am J Med; 1988 Sep; 85(3):327-30. PubMed ID: 2458039
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Inverse relationship between serum Lp(a) levels and first-phase insulin secretion.
    Sidhu M; Crook D; Godsland IF; Walton C; Wynn V; Oliver MF
    Diabetes; 1992 Oct; 41(10):1341-5. PubMed ID: 1397709
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Lipoprotein(a) and lipids in relation to inflammation in rheumatoid arthritis.
    Lee YH; Choi SJ; Ji JD; Seo HS; Song GG
    Clin Rheumatol; 2000; 19(4):324-5. PubMed ID: 10941819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.